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Key Clinical Message
We report a novel KRT13 germ line variant that causes white sponge nevus
(WSN) with mucosal dysplasia. Genital, vaginal, and cervical WSN were
observed in four female patients, of whom two had premalignant cervical
lesions at young age. Two of the 12 patients with oral WSN developed oral
squamous cell carcinoma.
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Introduction
White sponge nevus (WSN) is a rare, benign, and autoso-
mal dominant disorder, with no sex predilection. The dis-
order was first reported by Hyde in 1909, [1] and the
term “white sponge nevus” was coined in 1935 by Can-
non [2]. WSN (OMIM 193900) is caused by germ line
variants of the keratin genes KRT4 or KRT13, located,
respectively, at chromosomes 12q13 and 17q21-q22 [3, 4].
White sponge nevus is characterized by white spongy
plaques of the mucosa and predominantly affects nonker-
atinizing stratified epithelia such as the oral mucosa.
Extra-oral lesions are found in other mucosal sites, but
are relatively uncommon in the absence of oral manifesta-
tions. Extra-oral mucosal sites include the genital, laryn-
geal, and esophageal mucosa [5–9]. Extra-oral affected
sites have been shown to arise only from KRT13 variants.
The most frequent site affected was the vaginal mucosa
[10]. The histological features of WSN are acanthosis,
parakeratosis, cytoplasmic clearing of spinous layer ker-
atinocytes, and characteristic perinuclear eosinophilic con-
densations that correspond to abnormal aggregation of
cytokeratin tonofilaments [11]. The findings through
microscopic examination demonstrates that cytology can
be very useful in distinguishing WSN from other
histopathologically similar lesions [8].
Clinically, the lesions are characterized by the presence
of soft, white, and spongy plaques in the mucosa, of vari-
able sizes. The gynecological abnormalities are usually
asymptomatic, although pruritus, burning, and pain have
been reported to follow irritating stimuli [12]. The differ-
ential diagnosis for vulvar leukoplakia is vast and includes
inflammatory, premalignant/malignant, infectious, and
congenital abnormalities. Oral WSN may be confused
with leukoplakia, candidiasis, pachyonychia congenita,
hereditary benign intraepithelial dyskeratosis, Darier’s dis-
ease, dyskeratosis congenita, lichen planus, lupus erythe-
matosus, chemical burns induced by tobacco or betel nut
ª 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
This is an open access article under the terms of the Creative Commons Attribution License, which permits use,
distribution and reproduction in any medium, provided the original work is properly cited.
1503
use, and syphilis [8]. Distinction in this differential diag-
nosis is essential in terms of differences in treatment and
prognosis.
The majority of WSN are described in case reports,
and only a few larger families with WSN have been
reported and of these, only two had a KRT13 gene defect
[4, 8, 13]. Here, we report a four-generation family with
oral and gynecological manifestations of WSN caused by
a novel germ line variant in the KRT13 gene.
Subjects and Methods
Molecular genetic analysis
The index patient was sequenced for germ line variants in
the KRT4 and KRT13 genes. DNA was obtained from
peripheral blood by standard methods. Analysis of KRT4
and KRT13 sequences was performed by PCR amplifica-
tion of the coding regions and splice sites, including some
intronic sequences, with flanking-specific primers (pri-
mers and conditions available upon request) followed by
standard Sanger sequencing. Sequence analysis using
Sequence Pilot by JSI Medical Systems Corp.(USA) based
on KRT4 (NM_00272.2) and KRT13 (NM_153490.2).
Characterization of the detected variants at mRNA level
was performed by use of in silico prediction programs
and by analysis of the transcript by use of RT-PCR on
total RNA isolated from a short-term lymphocyte culture
[14, 15].
Clinical analysis of family members
A family gathering was organized for obtaining written
informed consent and DNA testing. The procedure was
approved by the medical ethical committee of the LUMC
(P12.113). A total of 20 family members donated blood for
DNA testing, and 22 persons completed a questionnaire on
manifestations of WSN, including age at diagnosis and
anatomical location. In addition, we asked them whether
they had complaints of the disorder, whether their children
were affected, and whether they had any tumors or any
other important diseases. Moreover, women were asked
whether they participated in the national cervical cancer
screening service. All family members underwent physical
examination by a dermatologist (M.V.). Seven of the 12
women opted for an examination by a gynecologist (A.P.).
The gynecological examination included an inspection of
the genital area and a pap smear.
Immunohistochemistry
Formalin-fixed paraffin-embedded tissue blocks were sec-
tioned at a thickness of 4 lm, dried, dewaxed, and
rehydrated by 0.3% H2O2/methanol. Antigen retrieval was
achieved by microwave oven treatment in 10 mmol/L
citrate buffer, ph 6.0, for staining of p53. Sections were
incubated overnight with monoclonal TP53 (clone DO-7;
Neomarkers, Ab-5) and 1:800 Keratin13 (clone AE8; Life
Span Biosciences). The sections were then incubated for
30 min with a secondary antibody (Poly-HRP-GAM/R/R;
DPV0110HPRP; Immunologic). Diaminobenzidine
tetrahydrochloride was used as a chromogen. The slides
were counterstained with hematoxylin.
Loss of heterozygosity analysis
Loss of Heterozygosity (LOH) analysis was performed as
previously described [16]. In short, 14 microsatellite
markers distributed on 12 chromosome arms, including
two markers on chromosome #17, were amplified by
DNA PCR using fluorochrome-labeled primers. The PCR
products were evaluated on a capillary sequencer (ABI).
The fluorescence intensity ratio of the two alleles of the
tumor DNA isolated from the two tumor samples and
were normalized using normal DNA from the same
patient. A ratio ≤0.75 was interpreted as AI (Allelic
Imbalance) and a ratio ≤0.5 as LOH.
Results
Clinical details
The index patient (IV-7, arrow in Fig. 1) was diagnosed
with WSN when she visited the Gynaecology Department
for anticonception at an age of 18 years. In 1991, micro-
scopic analysis of the cervix cytology showed Papanico-
laou score Pap3A (mild dysplasia). Upon review in
retrospect, the morphology was also compatible with
WSN, except that perinuclear eosinophilic condensations
were not visible. Additional testing on this biopsy
revealed no HPV involvement. At yearly follow-up, she
continuously had a cytological diagnosis of Pap2 or Pap1.
Repeat histology showed hyperplastic cervical squamous
epithelium and mild inflammation, but no dysplasia. She
did not have any complaints of dyspareunia or postcoital
bleeding. Last colposcopic examination showed thick
white epithelium covering most of the vagina and the
ectocervix. Exploration of oral cavity revealed white,
spongy, rough-looking lesions extending over the whole
oral mucosa, floor of the mouth, and side of the tongue,
which could not be removed by scratching.
The sister of the index patient (IV-8) was subsequently
diagnosed with WSN. At the age of 16 years, cervical
smear showed a Pap2 diagnosis. On last gynecological
examination, she was very sensitive in the genital area
and with mucosa prone to bleeding. Patient III-25 had a
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Pap3A in her cervical smear at an age of 27 years. In
these three women (IV-7, IV-8, and III-25), cytoplasmatic
aggregates of keratin were not reported, but a “HPV-cyto-
pathic effect” (with possible viral infection), pseudokoilo-
cytosis, and endocervical cylindric and squamous
metaplastic cells. Subsequently, HPV testing was per-
formed on the three Pap smears and was negative, despite
the cytology with viral-like features. Patient III-24 did not
give permission to study her historical medical files.
Gynecological WSN was observed in all four adult female
patients. A minor female (V-1) with oral WSN was not
examined by a gynecologist.
All variant carriers (see below) had oral WSN on
inspection. Oral biopsies were taken from patients III-25,
III-27, IV-3, and IV-4, and all showed a histology with
parakeratosis and mucosal hyperplasia resembling WSN.
The grandfather (II-10) and his daughter (III-24) both
had an oral tumor, respectively, aged 77 and 65 years.
Histopathological analysis showed well-differentiated
squamous cell carcinomas deriving from the oral mucosa.
Adjacent mucosa showed no WSN and HPV testing was
negative. Examples of clinical manifestations within this
family are depicted in Figure 2. None of the examined
males displayed genital WSN.
Molecular genetic analysis
Firstly, a heterozygous amino acid substitution in exon 2
of KRT4 (c.845G>A, p.Arg282His) was identified in the
index patient. However, this variant was not present in
her affected sister (IV-8). As the two sisters are similarly
affected, this variant did not appear to cause the pheno-
type. Moreover, this KRT4 variant is located outside the
conserved keratin domains where the vast majority of
pathogenic variants are located (www.interfil.org).
Secondly, both sisters were found to carry a heterozy-
gous 32-base pair deletion in intron 5 of KRT13
(c.1023+23_1024-39del). In silico analysis of the intronic
deletion by use of several splice prediction programs, visu-
alized by the Software program Alamut (Interactive
Biosoftware, France), did not show any predicted effect on
the splicing. The deletion did however take three possible
branch points. In vitro RNA analysis by use of RT-PCR
initially showed two very weak cDNA bands, indicating
aberrant splicing of exon 6. By PCR using primers in exon
4 and exon 7, the aberrant cDNA fragment was clearly
detectable in the RNA of the patient (III-25) Figure 3A.
Sequence analysis of the cDNA shows a heterozygous
deletion of 54 bases from the mRNA (r.1023-1077) Fig-
ure 3B, which causes an in-frame loss of 18 amino acids
from the KRT13 protein (p.Lys342_Gln359del).
Subsequently, we tested as many family members as
possible for cosegregation analysis of the KRT13 defect.
We found that the variant was present in all nine affected
family members that were available for testing but was
absent in 11 unaffected family members where DNA was
available (Fig. 1).
Haplotype analysis by use of six highly polymorphic
STR markers flanking the KRT13 gene shows within this
large Dutch family that this germ line variant did occur
de novo in the affected (WSN and oral squamous cell
carcinoma) great-grandfathers DNA and segregates on a
haplotype which does not carry the defect in the
unaffected part of the pedigree (Fig. 4).
Genetic analysis on the squamous cell carcinoma of
patient II-10 with markers on chromosome 17 (D17S799
and D17S588) demonstrated LOH at chromosomal loca-
tion 17p11.1 (where the p53 tumor suppressor gene is
located) but not on 17q21 where the KRT13 gene is located
(Fig. 5). Immunohistochemistry showed a wild-type stain-
ing pattern of P53 in the squamous cell carcinoma.
Immunohistochemical staining with keratin 13 antibod-
ies showed normal epithelial expression in the cervical tis-
sue of the index patient. In the oral squamous cell
carcinoma of patient II-10, a lower intensity of the
keratine 13 expression was observed.
Figure 1. Pedigree of the family. Family members clinically affected with WSN are shown in black. White symbols represent unaffected family
members. The presence (+) and absence () of the variant in tested individuals are shown under the symbols, that is, circle (woman) and block
(man). Diamond symbols represent either man or woman, with the number of family members annotated under the diamond. A diagonal line
represents that the person is deceased.
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Discussion
We report a large WSN family of four generations with 12
affected family members. Most commonly, keratin disor-
ders such as WSN are caused by missense or small in-frame
insertion/deletion variants clustered in the helix 1A domain
of the keratin polypeptide. Here, we identified a more
downstream variant – a 32-base pair deletion in intron 5 of
KRT13 (c.1023+23_1024-39del). We demonstrated (Fig. 3)
that this intronic deletion has an effect on the splicing
by quantitative RT-PCR and predicts an in-frame deletion
of the protein. So far, only missense variants in exon 1 of
human keratin 13 have been shown to be associated with
WSN [4, 13, 17–19]. Single amino acid alterations have
shown to produce defective keratin intermediate filaments
which form dense cytoplasmic aggregates in upper spinous
layers [4]. Apparently, larger defects in the structure of
KRT13 as identified here also result in a WSN phenotype.
The variant showed complete cosegregation with the
WSN phenotype in this family. Of the three large families
reported so far, two also showed full penetrance of the
disease [4, 13]. In one family, without molecular genetic
analysis of the keratin genes to confirm the diagnosis,
incomplete penetrance of the WSN phenotype was
reported [8]. The absence of both the KRT13 variant as
well as any clinical phenotype in the left side of the pedi-
gree supported by haplotype analysis prove that the vari-
ant occurred de novo in the grandfather of the index
patient. To our knowledge a de novo variant – also in
KRT13 – has been described once in WSN, but this was
based only on clinical information [18].
Our family presents a strong genotype–phenotype cor-
relation, that is, all nine carriers of the KRT13 germ line
variant are affected with WSN. Remarkably, all our
patients reported that they were affected from an early
age and that oral WSN was already recognized from birth.
Moreover, we observed genital, including vaginal, and
cervical WSN lesions in all four adult women. The index
patient, her sister, and paternal aunt had abnormal cervi-
cal smears at a relatively early age (18, 16, and 27 years,
respectively) in the absence of any apparent risk factors as
sexarche, or more than one sexual partner. WSN present-
ing as genital lesions has been described; however, this
was in the absence of vaginal or cervical involvement [7].
Remarkably, the grandfather of the index patient and
also his daughter developed a mucosal cancer. Marker
analysis on chromosomal location 17q21, in his oral
squamous cell carcinoma (patient II-10), did not show
LOH, suggesting that KRT13 does not act as a tumor
suppressor gene. Immunohistochemical staining with ker-
atin 13 antibodies showed strong expression in cervical
epithelial cells. The oral squamous cell carcinoma also
showed positive staining, although with somewhat lower
intensity. While a study of an oral squamous cell carci-
noma showed significant downregulation of keratin 4 and
keratin 13 expressions [20]. Keratin disorders are usually
caused by missense variants that result in aggregates of




Figure 2. Oral WSN (A): white to light rose-colored, fissured plaques
of the buccal mucosa and ventral surface of the tongue of one of the
family members (not specified, because of privacy reasons). Genital
WSN: thick white epithelium lines the inner surface of the labia
minora (B) and extends over the introitus (C). Family member not
specified, because of privacy reasons.
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perinuclear condensations of keratin aggregates in the
cervical and oral tissues of the individuals analyzed with
a non-missense variant, it is tempting to speculate that
there is a genotype–phenotype correlation in keratin 13
defects. Whether this or other keratin disorders have
(pre)malignant potential remains to be elucidated. To
our knowledge, these are the first findings of (pre)malig-
nancy in WSN. This observation warrants further investi-
gations in other WSN families and also to evaluate
whether these manifestations are related to a specific type
of KRT13 germ line variant.
The diagnosis of WSN should be made on detailed
patient and family history, inspection of mucosal lesions
by an experienced dermatologist, histopathology, and
molecular genetic analysis of the KRT4 and KRT13. The
cytological abnormalities observed and described by sev-
eral independent cytologists was not the result of HPV
infection, as HPV testing was negative. Clearly, the cytol-
ogy of genital WSN mimics that of HPV-related changes.
Given the wide differential diagnosis of white mucosal
lesions, an accurate diagnosis is important for treatment
and counseling of patients. WSN are reported to respond
on treatment with tetracycline, penicillin, or chlorhexidine
[21–23]. However, in cases where there is a lack of symp-
tomatic disease, conservative treatment is a good alterna-
tive [8]. So far, guidelines for clinical surveillance for
WSN are not available. Because of the uncertainty of the
tumorigenic potential of the disorder, our patients were
given the opportunity of an annual routine gynecological
checkup. Alternatively, patients with WSN can follow
national prevention programs. In the Netherlands, women
between the age of 30 and 60 years are offered screening
every 5 years with analysis of cervical smears. In addition,
it seems prudent to instruct patients to consult a derma-
tologist with any suspected mucosal lesion.
In addition, a correct diagnosis is not only important
for providing appropriate management and surveillance
but also for counseling of family members in the case of
WSN. Two of our family members reported to have white
oral lesions. However, examination by the dermatologist
(A)
(B)
Figure 3. cDNA PCR of the region exon 4-7 (A) shows an aberrant (shorter) fragment in the patient versus a control sample. Sequence analysis
of aberrant band (B) shows a deletion of the first part of exon 6 (1024–1077 = 54 base pair).
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showed candidiasis and neither of these individuals carried
the KRT13 variant. Both could be reassured that they did
not have WSN and could not pass this disorder on to their
offspring. Therefore, DNA analysis could be offered to
family members, mainly to rule out the diagnosis of WSN.
Considering recommendations for the surveillance of germ
line variant carriers of a keratin defect, more studies on
the clinical manifestations of WSN are warranted.
Conclusion
We describe a novel KRT13 variant, with a de novo ori-
gin in the great-grandfather, in a four-generation family
that causes WSN with full penetrance. This report adds
a number of novel aspects to what is known about
WSN. First, other mutations beside specific missense
variants in the 1A domain of the keratin 13 polypeptide
can cause WSN. Second, WSN involvement can extend
to vagina and cervix. Third, there is a remarkable inci-
dence of premalignant cervical lesions in affected women
and we also report the first malignant oral mucosal
lesions in WSN.
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